Page last updated: 2024-08-21

cuprizone and lysophosphatidylcholines

cuprizone has been researched along with lysophosphatidylcholines in 16 studies

Research

Studies (16)

TimeframeStudies, this research(%)All Research%
pre-19901 (6.25)18.7374
1990's0 (0.00)18.2507
2000's3 (18.75)29.6817
2010's10 (62.50)24.3611
2020's2 (12.50)2.80

Authors

AuthorsStudies
Blakemore, WF1
Franklin, RJ; Fruttiger, M; Richardson, WD; Woodruff, RH1
Alberta, JA; Arnett, HA; Fancy, SP; Franklin, RJ; Kaing, S; Plant, SR; Raine, CS; Rowitch, DH; Stiles, CD; Zhao, C1
Bernard, F; Chédotal, A; Franklin, RJ; Hu, B; Ji, B; Jung, V; Lee, X; Mason, J; Mi, S; Miklasz, S; Miller, RH; Pepinsky, B; Roulois, A; Shao, Z; Shea, D; Shields, CB; Tang, W; Wu, W; Xu, J; Zhang, Y1
Liu, B; Liu, Y; Sun, X; Xiao, Z; Zhang, L1
Rawji, KS; Yong, VW1
Bansal, R; Franklin, RJ; Furusho, M; Roulois, AJ1
Bittner, S; Budde, T; Cerina, M; Daldrup, T; Ehling, P; Göbel, K; Gudi, V; Herrmann, AM; Kleinschnitz, C; Meuth, P; Meuth, SG; Narayanan, V; Pape, HC; Ruck, T; Seidenbecher, T; Skripuletz, T; Stangel, M; Wiendl, H1
Brickey, WJ; David, CN; Freeman, L; Guo, H; Jha, S; Ting, JP1
Bahn, E; Brück, W; Junker, A; Scheidt, U; Schultz, V; Stadelmann, C; van der Meer, F; Wrzos, C1
Allinquant, B; Camand, E; Carrete, A; Chierto, E; Hendriks, JJA; Jafarian-Tehrani, M; Llufriu-Dabén, G; Mailleux, J; Massaad, C; Meffre, D; Rose, C; Simon, A; Vanmierlo, T1
Budde, T; Cerina, M; Daldrup, T; Fernandez-Orth, J; Göbel, K; Gudi, V; Herrmann, AM; Lesting, J; Meuth, P; Meuth, SG; Narayanan, V; Pape, HC; Schiffler, P; Seidenbecher, T; Skripuletz, T; Stangel, M; Wiendl, H1
Baumgartner, L; de Vries, R; Galeno, G; Good, A; Good, N; Hlavica, M; Hooijmans, CR; Ineichen, BV; Jung, T; Schneider, MP; Schuler, FAF1
Franklin, RJM; McMurran, CE; Zhao, C1
Choi, CI; Kim, HN; Kleppe, LS; Langley, MR; Scarisbrick, IA; Simon, WL; Triplet, EM; Yoon, H1
Huang, JK; Kouki, T; Ohno, N; Osanai, Y; Yamazaki, R1

Reviews

2 review(s) available for cuprizone and lysophosphatidylcholines

ArticleYear
The benefits and detriments of macrophages/microglia in models of multiple sclerosis.
    Clinical & developmental immunology, 2013, Volume: 2013

    Topics: Animals; Cell Movement; Central Nervous System; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Humans; Immunologic Factors; Lysophosphatidylcholines; Macrophages; Microglia; Multiple Sclerosis; Neurons; Oligodendroglia; T-Lymphocytes

2013
Remyelination promoting therapies in multiple sclerosis animal models: a systematic review and meta-analysis.
    Scientific reports, 2019, 01-29, Volume: 9, Issue:1

    Topics: Animals; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Encephalomyelitis, Autoimmune, Experimental; Ethidium; Eye Proteins; Lysophosphatidylcholines; Mice; Multiple Sclerosis; Myelin Sheath; Nerve Growth Factors; Oligodendrocyte Precursor Cells; Oligodendroglia; Platelet-Derived Growth Factor; Remyelination; Serpins; Tocopherols

2019

Other Studies

14 other study(ies) available for cuprizone and lysophosphatidylcholines

ArticleYear
Remyelination in the CNS.
    Progress in clinical and biological research, 1981, Volume: 59A

    Topics: 6-Aminonicotinamide; Animals; Axons; Brain; Cats; Cuprizone; Lysophosphatidylcholines; Myelin Sheath; Oligodendroglia; Rabbits; Spinal Cord

1981
Platelet-derived growth factor regulates oligodendrocyte progenitor numbers in adult CNS and their response following CNS demyelination.
    Molecular and cellular neurosciences, 2004, Volume: 25, Issue:2

    Topics: Animals; Central Nervous System; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Glial Fibrillary Acidic Protein; Lysophosphatidylcholines; Mice; Mice, Transgenic; Nerve Regeneration; Oligodendroglia; Platelet-Derived Growth Factor; Promoter Regions, Genetic; Stem Cells; Up-Regulation

2004
bHLH transcription factor Olig1 is required to repair demyelinated lesions in the CNS.
    Science (New York, N.Y.), 2004, Dec-17, Volume: 306, Issue:5704

    Topics: Animals; Animals, Newborn; Basic Helix-Loop-Helix Transcription Factors; Brain; Cell Nucleus; Cuprizone; Cytoplasm; Demyelinating Diseases; DNA-Binding Proteins; Ethidium; Humans; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Nerve Tissue Proteins; Oligodendrocyte Transcription Factor 2; Oligodendroglia; Rats; Rats, Sprague-Dawley; Spinal Cord; Stem Cells; Transcription Factors

2004
Promotion of central nervous system remyelination by induced differentiation of oligodendrocyte precursor cells.
    Annals of neurology, 2009, Volume: 65, Issue:3

    Topics: Animals; Animals, Newborn; Antibodies; Cell Differentiation; Cells, Cultured; Cuprizone; Demyelinating Autoimmune Diseases, CNS; Disease Models, Animal; Ganglia, Spinal; Lysophosphatidylcholines; Membrane Proteins; Mice; Myelin Proteins; Myelin Sheath; Nerve Tissue Proteins; Oligodendroglia; Organ Culture Techniques; Rats; Rats, Sprague-Dawley; Stem Cells

2009
Rolipram promotes remyelination possibly via MEK-ERK signal pathway in cuprizone-induced demyelination mouse.
    Experimental neurology, 2012, Volume: 237, Issue:2

    Topics: Animals; Blotting, Western; Brain; Cell Differentiation; Cuprizone; Demyelinating Diseases; Lysophosphatidylcholines; MAP Kinase Signaling System; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Oligodendroglia; Organ Culture Techniques; Phosphodiesterase 4 Inhibitors; Rats; Rats, Sprague-Dawley; Rolipram; Stem Cells

2012
Fibroblast growth factor signaling in oligodendrocyte-lineage cells facilitates recovery of chronically demyelinated lesions but is redundant in acute lesions.
    Glia, 2015, Volume: 63, Issue:10

    Topics: 2',3'-Cyclic Nucleotide 3'-Phosphodiesterase; Animals; Animals, Newborn; Basic Helix-Loop-Helix Transcription Factors; Cell Differentiation; Cell Lineage; Cells, Cultured; Chelating Agents; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Fibroblast Growth Factors; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Mice, Transgenic; Oligodendroglia; Receptor, Fibroblast Growth Factor, Type 1; Receptor, Fibroblast Growth Factor, Type 2; Recovery of Function; Signal Transduction; Spinal Cord

2015
The quality of cortical network function recovery depends on localization and degree of axonal demyelination.
    Brain, behavior, and immunity, 2017, Volume: 59

    Topics: Adaptive Immunity; Animals; Behavior, Animal; Cerebral Cortex; Cuprizone; Demyelinating Diseases; Electrodes, Implanted; Gray Matter; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Myelin Sheath; Nerve Net; Recovery of Function; Sensation; White Matter

2017
NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes.
    The Journal of experimental medicine, 2017, 05-01, Volume: 214, Issue:5

    Topics: Animals; Apoptosis Regulatory Proteins; Astrocytes; Calcium-Binding Proteins; Cuprizone; Disease Models, Animal; Inflammasomes; Inflammation; Lysophosphatidylcholines; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Microglia; NLR Family, Pyrin Domain-Containing 3 Protein

2017
Acutely damaged axons are remyelinated in multiple sclerosis and experimental models of demyelination.
    Glia, 2017, Volume: 65, Issue:8

    Topics: Amyloid beta-Protein Precursor; Animals; Axons; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Female; Glial Fibrillary Acidic Protein; Lysophosphatidylcholines; Male; Membrane Proteins; Mice; Mice, Inbred C57BL; Microglia; Monoamine Oxidase Inhibitors; Multiple Sclerosis; Myelin Sheath; Rats; Rats, Inbred Lew; Statistics, Nonparametric; Time Factors

2017
Targeting demyelination via α-secretases promoting sAPPα release to enhance remyelination in central nervous system.
    Neurobiology of disease, 2018, Volume: 109, Issue:Pt A

    Topics: Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Animals; Axons; Brain; Cells, Cultured; Cerebellum; Corpus Callosum; Cuprizone; Demyelinating Diseases; Etazolate; Lysophosphatidylcholines; Male; Mice, Inbred C57BL; Myelin Sheath; Neuroprotective Agents; Remyelination

2018
Impairment of frequency-specific responses associated with altered electrical activity patterns in auditory thalamus following focal and general demyelination.
    Experimental neurology, 2018, Volume: 309

    Topics: Acoustic Stimulation; Action Potentials; Animals; Auditory Cortex; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Female; Functional Laterality; Geniculate Bodies; Gliosis; Gray Matter; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Myelin Proteolipid Protein; Neurons; Psychoacoustics; Thalamus

2018
Toxin-Based Models to Investigate Demyelination and Remyelination.
    Methods in molecular biology (Clifton, N.J.), 2019, Volume: 1936

    Topics: Animals; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Ethidium; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Rats; Remyelination

2019
Blocking the Thrombin Receptor Promotes Repair of Demyelinated Lesions in the Adult Brain.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2020, 02-12, Volume: 40, Issue:7

    Topics: Animals; Astrocytes; Axons; Brain-Derived Neurotrophic Factor; Chelating Agents; Coculture Techniques; Copper; Corpus Callosum; Cuprizone; Demyelinating Diseases; Gene Expression Profiling; Lysophosphatidylcholines; Male; Mice; Mice, Knockout; Myelin Sheath; Nerve Regeneration; Neural Stem Cells; Oligodendroglia; Receptor, PAR-1; Rotarod Performance Test; Spinal Cord; White Matter

2020
Pharmacological treatment promoting remyelination enhances motor function after internal capsule demyelination in mice.
    Neurochemistry international, 2023, Volume: 164

    Topics: Animals; Clemastine; Cuprizone; Demyelinating Diseases; Disease Models, Animal; Internal Capsule; Lysophosphatidylcholines; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Myelin Sheath; Oligodendroglia; Remyelination

2023